WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
'The firm' leads US efforts to ease blowback for countries targeted by China
Vermont governor vetoes bill to restrict pesticide that is toxic to bees, saying it's anti
Wisconsin regulators investigating manure spill that caused mile
Feature: Innovation turns switch producer into global energy solutions provider
A Minnesota city will rewrite an anti
Concussion replacements added for Copa America under the pink substitution pass system
Jailed Guatemalan journalist to AP: 'I can defend myself, because I am innocent'
Xinhua Commentary: Asia's development vitality hinges on stronger China
José Ramírez drives in 3 runs as the AL Central
Sierra Leone: A cheap synthetic drug called kush is ravaging youth
José Ramírez drives in 3 runs as the AL Central